Home - Sana Biotechnology
Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease.
Sana Biotechnology, Inc. (SANA) - Yahoo Finance
Find the latest Sana Biotechnology, Inc. (SANA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sana Biotechnology Announces Positive Clinical Results from …
Jan 7, 2025 · First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression.
Our Science - Sana Biotechnology
We are developing platforms that can repair and control genes in cells or replace any cell in the body. We work with leading academic laboratories and industry partners on research and development related to our technologies.
Sana stock price triples after allogeneic cell therapy data drop
Jan 8, 2025 · Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.
Our Pipeline - Sana Biotechnology
We never lose sight of why our work matters – the potential to impact the lives of patients is important to everyone at Sana. We are advancing a number of innovative drug candidates with the goal of disrupting the possible for patients across a diverse set of diseases.
Sana strips back cancer, CNS programs while warning of layoffs
Nov 5, 2024 · Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a strategic refocus that sounds likely to include a side order...
Sana Biotechnology Announces FDA Clearance of Investigational …
Nov 9, 2023 · Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients.
Sana Biotechnology Confirms Key Program Timelines and …
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients.
Sana Biotechnology Announces Positive Clinical Results from …
Jan 7, 2025 · Results Demonstrate HIP-Engineered Primary Pancreatic Islet Cells Avoid Immune Detection, Function, and Persist after Intramuscular Transplantation in First Treated Patient with Type 1 Diabetes.
- Some results have been removed